Charles Kouanfack, Faculty of Medicine and Pharmaceutical Sciences University of Dschang
Faculty of Medicine and Pharmaceutical Sciences University of DschangMedical Doctor and Phd Public Health
Presenter Of 1 Presentation
Oral abstract session
OAB0402 - Dolutegravir- versus low-dose Efavirenz-based regimen for the initial treatment of HIV-1 infection in Cameroon: Week 96 results of the ANRS 12313 – NAMSAL trial
Session Name
Room
Abstract Sessions On-Demand Channel
Presenter Of 1 Presentation
Oral abstract session
Dolutegravir- versus low-dose Efavirenz-based regimen for the initial treatment of HIV-1 infection in Cameroon: Week 96 results of the ANRS 12313 – NAMSAL trial
Session Name
Room
Abstract Sessions On-Demand Channel
Presenter Of 1 Presentation
Oral abstract session
Dolutegravir- versus low-dose Efavirenz-based regimen for the initial treatment of HIV-1 infection in Cameroon: Week 96 results of the ANRS 12313 – NAMSAL trial
Session Name
Room
Abstract Sessions On-Demand Channel